WO2015091089A1 - Protéases fongiques et leur utilisation dans des produits de lavage et de nettoyage - Google Patents

Protéases fongiques et leur utilisation dans des produits de lavage et de nettoyage Download PDF

Info

Publication number
WO2015091089A1
WO2015091089A1 PCT/EP2014/076976 EP2014076976W WO2015091089A1 WO 2015091089 A1 WO2015091089 A1 WO 2015091089A1 EP 2014076976 W EP2014076976 W EP 2014076976W WO 2015091089 A1 WO2015091089 A1 WO 2015091089A1
Authority
WO
WIPO (PCT)
Prior art keywords
protease
amino acid
acid sequence
proteases
agent
Prior art date
Application number
PCT/EP2014/076976
Other languages
German (de)
English (en)
Inventor
Hendrik Hellmuth
Thomas Weber
Timothy O'connell
Susanne Tondera
Diana Linke
Ralf G. Berger
Robin-Hagen LEONHARDT
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP14827182.8A priority Critical patent/EP3083955A1/fr
Publication of WO2015091089A1 publication Critical patent/WO2015091089A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi

Definitions

  • the invention is in the field of enzyme technology.
  • the invention relates to fungal proteases which are suitable for use in detergents and cleaners, all sufficiently similar proteases and nucleic acids coding for them and their preparation.
  • the invention further relates to methods and uses of these proteases and agents containing them, in particular washing and cleaning agents.
  • proteases are among the most technically important enzymes of all. For detergents and cleaners, they are the longest established and contained in virtually all modern, powerful detergents and cleaners enzymes. They cause the degradation of protein-containing stains on the items to be cleaned. Of these, in turn, proteases of the subtilisin type (subtilases, subtilopeptidases, EC 3.4.21 .62) are particularly important, which are serine proteases due to the catalytically active amino acids. They act as nonspecific endopeptidases and hydrolyze any acid amide linkages that are internal to peptides or proteins. Their pH optimum is usually in the clearly alkaline range.
  • Subtilases Subtilisin-like Proteases
  • R. Siezen pages 75-95 in "Subtilisin enzymes", edited by R. Bott and C. Betzel, New York, 1996.
  • Subtilases are naturally occurring formed by microorganisms. Of these, in particular, the subtilisins formed and secreted by Bacillus species are to be mentioned as the most important group within the subtilases.
  • proteases preferably used in detergents and cleaners from
  • Subtilisin type are the subtilisins BPN 'and Carlsberg, the protease PB92, the subtilisins 147 and 309, the protease from Bacillus lentus, in particular from Bacillus lentus DSM 5483,
  • proteases mentioned above are all of bacterial origin and belong to protein families which have a high degree of homology with each other. Despite the widespread use of proteases as constituents of detergents and cleaners, there is still a need for alternative proteases, especially with improved performance in certain applications. In particular, there is a need for alternative proteases that do not fall within the narrow sequence space of known bacterial proteases, but provide new sequence spaces that can then be subsequently optimized for particular applications.
  • a protease comprising an amino acid sequence corresponding to the in SEQ ID NO. 1 amino acid sequence over its entire length has a sequence identity of at least 95.4% or sequence homology of at least 98%.
  • nucleic acids coding for these proteases include the nucleic acids coding for these proteases, the non-human host cells containing proteases or nucleic acids according to the invention.
  • the invention relates, in further aspects, to agents, in particular detergents and cleaners, which comprise a protease comprising an amino acid sequence which corresponds to the amino acid sequence shown in SEQ ID NO. 1 amino acid sequence throughout its length has a sequence identity or sequence homology of at least 70%, preferably of at least 80%, more preferably at least 90%, or contains functional fragments thereof.
  • agents in particular detergents and cleaners, which comprise a protease comprising an amino acid sequence which corresponds to the amino acid sequence shown in SEQ ID NO. 1 amino acid sequence throughout its length has a sequence identity or sequence homology of at least 70%, preferably of at least 80%, more preferably at least 90%, or contains functional fragments thereof.
  • Other aspects also concern processes using these agents and the uses as such.
  • the present invention is based on the surprising finding of the inventors that a protease of the invention in detergents and cleaners causes a good cleaning performance, which is even better than the established reference enzymes in certain areas.
  • a protease according to the invention has a proteolytic activity, that is, it is capable of hydrolysing peptide bonds of a polypeptide or protein, in particular in a washing or cleaning agent.
  • a protease according to the invention is therefore an enzyme which catalyzes the hydrolysis of peptide bonds and thereby is able to cleave peptides or proteins.
  • a protease according to the invention is preferably a mature protease, ie the catalytically active molecule without signal and / or propeptide (s). Unless otherwise stated, the sequences given refer to each mature enzyme.
  • the protease comprises an amino acid sequence which corresponds to the amino acid sequence shown in SEQ ID NO.
  • the protease comprises a
  • Amino acid sequence corresponding to that shown in SEQ ID NO. 1 at least 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, of their total length.
  • sequence comparison is based on the BLAST algorithm established and commonly used in the prior art (see, for example, Altschul, SF, Gish, W., Miller, W., Myers, EW & Lipman, DJ. (1990) "Basic local alignment search Biol. 215: 403-410; and Altschul, Stephan F., Thomas L. Madden, Alejandro A. Schaffer, Jinghui Zhang, Hheng Zhang, Webb Miller, and David J.
  • Lipman (1997): "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs"; Nucleic Acids Res., 25, pp.3389-3402) and is in principle accomplished by similar sequences of nucleotides or amino acids in the nucleic acid or amino acid sequences of each other be assigned. A tabular assignment of the respective positions is referred to as alignment.
  • Another algorithm available in the prior art is the FASTA algorithm. Sequence comparisons (alignments), in particular multiple sequence comparisons, are created with computer programs.
  • Identity and / or homology information can be made about whole polypeptides or genes or only over individual regions. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by matches in the sequences. Such areas often have identical functions. They can be small and comprise only a few nucleotides or amino acids. Often, such small regions exert essential functions for the overall activity of the protein. It may therefore be useful to relate sequence matches only to individual, possibly small areas. Unless otherwise indicated, identity or homology information in the present application, however, refers to the total length of the particular nucleic acid or amino acid sequence indicated.
  • Amino acid position of a numerically designated position in SEQ ID NO. 1 therefore corresponds to the corresponding position being assigned to the numerically designated position in SEQ ID NO. 1 in an alignment as defined above.
  • the protease is characterized in that its purification performance is not significantly reduced compared to that of a protease comprising an amino acid sequence corresponding to the amino acid sequence given in SEQ ID NO: 1, i. has at least 80% of the reference washing performance.
  • the cleaning performance can be determined in a washing system containing a detergent in a dosage between 4.5 and 7.0 grams per liter of wash liquor and the protease, wherein the proteases to be compared in concentration (based on active protein) are used and the cleaning performance against A cotton soiling is determined by measuring the whiteness of the washed fabrics, washing for 70 minutes at one
  • the concentration of the protease in the detergent intended for this washing system is from 0.001-0, 1 wt .-%, preferably from 0.01 to 0.06 wt .-%, based on active protein.
  • a preferred liquid detergent for such a washing system is composed as follows (all figures in weight percent): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7%
  • the dosage of the liquid detergent is between 4.5 and 6.0 grams per liter of wash liquor, for example, 4.7, 4.9 or 5.9 grams per liter of wash liquor.
  • a preferred powdered detergent for such a washing system is composed as follows (all figures in weight percent): 10% linear alkylbenzenesulfonate (sodium salt), 1.5% C12-C18 fatty alcohol sulfate (sodium salt), 2.0% C12-C18 fatty alcohol with 7 EO, 20%
  • the dosage of the powdered detergent is between 4.5 and 7.0 grams per liter of wash liquor, for example, and more preferably 4.7 grams per liter of wash liquor, or 5.5, 5.9 or 6.7 grams per liter of wash liquor. Preference is given to washing in a pH range between pH 9 and pH 11.
  • the degree of whiteness i. the brightening of the stains, as a measure of the cleaning performance is preferably determined by optical measurement methods, preferably photometrically.
  • a suitable device for this purpose is for example the spectrometer Minolta CM508d.
  • the devices used for the measurement are previously calibrated with a white standard, preferably a supplied white standard.
  • the protease activity can be determined via the release of the chromophore para-nitroaniline (pNA) from the substrate suc-L-Ala-L-Ala-L-Pro-L-Phe-p-Nitroanilide (AAPF).
  • pNA chromophore para-nitroaniline
  • AAPF suc-L-Ala-L-Ala-L-Pro-L-Phe-p-Nitroanilide
  • the protease cleaves the substrate and releases pNA.
  • the release of pNA causes an increase in absorbance at 410 nm, the time course of which is a measure of enzymatic activity (see Del Mar et al., 1979).
  • the Measurement takes place at a temperature of 25 ° C, at pH 8.6, and a wavelength of 410 nm.
  • the measuring time is 5 min and the measuring interval 20s to 60s.
  • the protease activity is usually indicated in protease units (PE). Suitable protease activities are, for example, 2.25, 5 or 10 PE per ml wash liquor. However, the protease activity is not equal to zero.
  • the protein concentration can be determined by known methods, for example, the BCA method (bicinchoninic acid, 2,2'-biquinolyl-4,4'-dicarboxylic acid) or the biuret method (AG Gornall, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766).
  • the determination of the active protein concentration in this regard can be carried out by titration of the active sites using a suitable irreversible inhibitor (for proteases, for example phenylmethylsulfonyl fluoride (PMSF)) and determination of the residual activity (see M. Bender et al., J. Am. Chem. Soc 24 (1966), pp. 5890-5913).
  • a suitable irreversible inhibitor for proteases, for example phenylmethylsulfonyl fluoride (PMSF)
  • Proteins can be grouped into groups of immunologically related proteins by reaction with an antiserum or antibody.
  • the members of such a group are characterized by having the same antigenic determinant recognized by an antibody. They are therefore structurally so similar to each other that they are recognized by an antiserum or specific antibodies.
  • a further subject of the invention therefore proteases, which are characterized in that they have at least one and increasingly preferably two, three or four matching antigenic determinants with a protease according to the invention. Due to their immunological similarities, such proteases are structurally so structurally similar to the proteases according to the invention that a similar function can also be assumed.
  • proteases of the invention may have one or more amino acid changes, in particular amino acid substitutions, insertions or deletions.
  • Such proteases are, for example, by targeted genetic modification, i. by mutagenesis, further developed and optimized for specific applications or specific properties (for example, in terms of catalytic activity, stability, etc.).
  • nucleic acids according to the invention can be introduced into recombination mixtures and thus used for
  • the goal is to introduce into the known molecules targeted mutations such as substitutions, insertions or deletions, for example, to improve the cleaning performance of enzymes of the invention.
  • targeted mutations such as substitutions, insertions or deletions, for example, to improve the cleaning performance of enzymes of the invention.
  • the surface charges and / or the isoelectric point of the molecules and thereby their interactions with the substrate can be changed.
  • the net charge of the enzymes can be changed in order to influence the substrate binding, in particular for use in detergents and cleaners.
  • the stability of the protease can be further increased by one or more corresponding mutations, thereby improving its purification performance.
  • amino acid exchanges the following convention is used: first, the naturally occurring amino acid in the form of the international one-letter code is called, then follows the associated sequence position and finally the inserted amino acid. Several exchanges within the same polypeptide chain are separated by slashes. For insertions, additional amino acids are named after the sequence position. In the case of deletions, the missing amino acid is replaced by a symbol, for example a star or a dash, or a ⁇ is specified in front of the corresponding position. For example, A95G describes the substitution of alanine at position 95 by glycine, A95AG the insertion of glycine after the amino acid alanine at position 95 and A95 * or ⁇ 95 the deletion of alanine at position 95. This nomenclature is known to those skilled in the art of enzyme technology.
  • Another object of the invention is therefore a protease which is characterized in that it is obtainable from a protease as described above as the starting molecule by one or more conservative amino acid substitution.
  • conservative amino acid substitution The term "conservative
  • amino acid substitution means the replacement of one amino acid residue with another amino acid residue, which substitution does not result in a change in polarity or charge at the position of the exchanged amino acid, e.g., the replacement of a nonpolar amino acid residue with another nonpolar amino acid residue
  • the protease is characterized in that it is obtainable from a protease according to the invention as starting molecule by fragmentation, deletion,
  • Insertion or substitution mutagenesis and an amino acid sequence over a length of at least 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, 250, 260, 270, 272, 274, 276, 278, 280, 282, 284, 285, 287, 289, 291, 292, 293, 294, 295, or 296 are consistent with the parent molecule.
  • their proteolytic activity i. their proteolytic activity is at least equal to that of the parent enzyme, i. In a preferred embodiment, the proteolytic activity is at least 80, preferably at least 90% of the activity of the
  • Another object of the invention is a protease described above, which is additionally stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer.
  • a protease described above which is additionally stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer.
  • all stabilization options described in the prior art and / or appropriate considerations come into consideration. Preference is given to those stabilizations which are achieved via mutations of the enzyme itself, since such stabilizations do not require any further working steps following the recovery of the enzyme. Examples of sequence changes suitable for this purpose are mentioned above. Other suitable sequence changes are known from the prior art.
  • proteases can also be stabilized by replacing one or more tyrosine residues with other amino acids.
  • amino acid (s) involved in the calcium binding with one or more negatively charged amino acids and / or by introducing sequence changes in at least one of the sequences of the two amino acids arginine / glycine;
  • Preferred embodiments are those in which the enzyme is stabilized in several ways, as several stabilizing mutations act additive or synergistic.
  • Another object of the invention is a protease as described above, which is characterized in that it has at least one chemical modification.
  • a protease with such a change is called a derivative, ie the protease is derivatized.
  • derivatives are understood as meaning those proteins whose pure amino acid chain has been chemically modified.
  • Derivatizations can be made, for example, in vivo by the host cell expressing the protein. In this regard, couplings of low molecular weight compounds such as lipids or oligosaccharides are particularly noteworthy. However, derivatizations can also be carried out in vitro, for example by the chemical transformation of a side chain of an amino acid or by covalent binding of another compound to the protein. For example, the coupling of amines to carboxyl groups of an enzyme to alter the isoelectric point is possible. Such another compound may also be another protein that is bound to a protein of the invention via bifunctional chemical compounds, for example. Similarly, derivatization is the covalent bond to a
  • Derivatizations may, for example, affect the substrate specificity or binding strength to the substrate or cause a temporary blockage of the enzymatic activity when the coupled substance is an inhibitor. This can be useful, for example, for the period of storage. Such modifications may further affect stability or enzymatic activity. They can also serve to reduce the allergenicity and / or immunogenicity of the protein and thus, for example, increase its skin compatibility. For example, couplings with macromolecular compounds, for example, polyethylene glycol, can improve the protein in terms of stability and / or skin tolerance.
  • a protein may be associated with various other substances, for example from the culture of the producing microorganisms.
  • a protein may also have been deliberately added to other substances, for example to increase its storage stability.
  • proteases with protease inhibitors
  • Another object of the invention is a nucleic acid encoding a protease of the invention, and a vector containing such a nucleic acid, in particular a
  • the nucleic acid can comprise or consist of the nucleotide sequence according to SEQ ID NO: 4 or the parts of the sequence according to SEQ ID NO: 4 coding for the protease according to SEQ ID NO.1 or their precursors according to SEQ ID NO: 5 or 6.
  • DNA or RNA molecules may be DNA or RNA molecules. They can be present as a single strand, as a single strand that is complementary to this single strand, or as a double strand. Especially in the case of DNA molecules, the sequences of both complementary strands must be taken into account in all three possible reading frames. Furthermore, it should be noted that different codons, so base triplets, can code for the same amino acids, so that a particular amino acid sequence can be encoded by several different nucleic acids. Due to this degeneracy of the genetic code, all nucleic acid sequences are included in this subject of the invention which can encode any of the proteases described above.
  • nucleic acid sequences unequivocally since, despite the degeneracy of the genetic code, individual codons are assigned defined amino acids. Therefore, the person skilled in the art can easily determine nucleic acids coding for this amino acid sequence on the basis of an amino acid sequence.
  • one or more codons may be replaced by synonymous codons.
  • This aspect relates in particular to the heterologous expression of the enzymes according to the invention.
  • each organism for example a host cell of a production strain, has a particular codon usage. Codon usage is understood to mean the translation of the genetic code into amino acids by the particular organism.
  • Bottlenecks in protein biosynthesis can occur if the codons lying on the nucleic acid in the organism face a comparatively small number of loaded tRNA molecules. Although coding for the same amino acid, this results in a codon being translated less efficiently in the organism than a synonymous codon encoding the same amino acid. Due to the presence of a higher number of tRNA molecules for the synonymous codon, it can be more efficiently translated in the organism.
  • a person skilled in the art can use well-known methods such as chemical synthesis or the polymerase chain reaction (PCR) in combination with molecular biological and / or proteinchemical standard methods, using known DNA and / or amino acid sequences, the corresponding nucleic acids to complete genes manufacture. Such methods are known, for example, from Sambrook, J., Fritsch, EF and Maniatis, T. 2001. Molecular cloning: a laboratory manual, 3rd Edition Cold Spring Laboratory Press.
  • vectors are understood as consisting of nucleic acids which contain a nucleic acid according to the invention as a characteristic nucleic acid region. They can establish these in a species or cell line over several generations or cell divisions as a stable genetic element.
  • Vectors especially when used in bacteria, are special plasmids, ie circular genetic elements.
  • a nucleic acid according to the invention is cloned into a vector.
  • the vectors include, for example, those whose origin are bacterial plasmids, viruses or bacteriophages, or predominantly synthetic vectors or plasmids with elements of various origins. With the other genetic elements present in each case, vectors are able to establish themselves as stable units in the relevant host cells over several generations. They may be extra chromosomally present as separate units or integrated into a chromosome or chromosomal DNA.
  • Expression vectors comprise nucleic acid sequences which enable them to replicate in the host cells containing them, preferably microorganisms, particularly preferably bacteria, and to express a contained nucleic acid there.
  • expression is influenced by the promoter (s) that regulate transcription.
  • the expression may be effected by the natural promoter originally located in front of the nucleic acid to be expressed, but also by a promoter of the host cell provided on the expression vector or also by a modified or completely different promoter of another organism or another host cell.
  • at least one promoter for the expression of a nucleic acid according to the invention is made available and used for its expression.
  • expression vectors can be regulatable, for example by changing the culturing conditions or when a specific cell density of the host cells contained therein is reached or by addition of specific substances, in particular activators of gene expression.
  • An example of such a substance is the galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside (IPTG), which is used as an activator of the bacterial lactose operon (lac operon).
  • IPTG galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside
  • lac operon lac operon
  • a further subject of the invention is a non-human host cell which contains a nucleic acid according to the invention or a vector according to the invention or which contains a protease according to the invention, in particular one which secretes the protease into the medium surrounding the host cell.
  • a nucleic acid according to the invention or a vector according to the invention is transformed into a microorganism, which then represents a host cell according to the invention.
  • individual components, ie nucleic acid parts or fragments of a nucleic acid according to the invention can be introduced into a host cell such that the resulting host cell contains a nucleic acid according to the invention or a vector according to the invention.
  • This procedure is particularly suitable when the host cell already contains one or more constituents of a nucleic acid according to the invention or a vector according to the invention and the further constituents are then supplemented accordingly.
  • Methods of transforming cells are well established in the art and well known to those skilled in the art. In principle, all cells, that is to say prokaryotic or eukaryotic cells, are suitable as host cells. Preference is given to those host cells which can be handled genetically advantageously, for example as regards the transformation with the nucleic acid or the vector and its stable establishment, for example unicellular fungi or bacteria. Furthermore, preferred host cells are characterized by a good microbiological and
  • Preferred host cells according to the invention secrete the (transgenially) expressed protein into the medium surrounding the host cells.
  • the proteases can be modified by the cells producing them after their production, for example by attachment of sugar molecules, formylations, aminations, etc. Such post-translational modifications can functionally influence the protease.
  • inventions are those host cells which are regulatable in their activity due to genetic regulatory elements which are provided, for example, on the vector, but may also be present in these cells from the outset.
  • Preferred host cells are prokaryotic or bacterial cells. Bacteria are characterized by short generation times and low demands on cultivation conditions. As a result, inexpensive cultivation methods or production methods can be established. In addition, the expert has a wealth of experience in bacteria in fermentation technology. For a special production can be made of different, in individual cases for reasons to be determined experimentally, such as nutrient sources, product formation rate, time requirement, etc., gram-negative or gram-positive bacteria.
  • Gram-negative bacteria such as Escherichia coli
  • Gram-negative bacteria can also be designed such that they eject the expressed proteins not only into the periplasmic space but into the medium surrounding the bacterium.
  • Gram-positive bacteria such as Bacilli or Actinomycetes or other representatives of Actinomycetales have no outer membrane, so that secreted proteins readily into the medium surrounding the bacteria, usually the
  • Nutrient medium can be dispensed, from which the expressed proteins can be purified. They can be isolated directly from the medium or further processed.
  • Gram-positive bacteria are related or identical to most of the organisms of origin for technically important enzymes and usually form even comparable enzymes, so they have a similar codon use and their protein synthesizer is naturally aligned accordingly.
  • Host cells according to the invention may be altered in their requirements of the culture conditions, have different or additional selection markers or express other or additional proteins. In particular, it may also be those host cells which express several proteins or enzymes transgene.
  • the present invention is applicable in principle to all microorganisms, in particular to all fermentable microorganisms, particularly preferably those of the genus Bacillus, and results in the production of proteins according to the invention by the use of such microorganisms. Such microorganisms then represent host cells in the sense of the invention.
  • the host cell is characterized in that it is a bacterium, preferably one selected from the genera of Escherichia, Klebsiella, Bacillus, Staphylococcus, Corynebacterium, Arthrobacter, Streptomyces, Stenotrophomonas and Pseudomonas, more preferably one selected from the group consisting of Escherichia coli, Klebsiella planticola, Bacillus licheniformis, Bacillus lentus, Bacillus amyloliquefaciens, Bacillus subtilis, Bacillus alcalophilus, Bacillus globigii, Bacillus gibsonii, Bacillus clausii, Bacillus halodurans, Bacillus pumilus, Staphylococcus carnosus, Corynebacterium glutamicum , Arthrobacter oxidans, Streptomyces lividans, Streptomyces coelicolor and
  • the host cell may also be a eukaryotic cell, which is characterized in that it has a cell nucleus.
  • a further subject of the invention therefore represents a host cell, which is characterized in that it has a cell nucleus.
  • eukaryotic cells are capable of producing the protein formed
  • fungi such as Actinomycetes or yeasts such as Saccharomyces or Kluyveromyces.
  • yeasts such as Saccharomyces or Kluyveromyces.
  • Modifications that eukaryotic systems perform, especially in connection with protein synthesis include, for example, the binding of low molecular weight compounds such as membrane anchors or oligosaccharides.
  • oligosaccharide modifications may be desirable, for example, to lower the allergenicity of an expressed protein.
  • coexpression with the enzymes naturally produced by such cells, such as cellulases or lipases may be advantageous.
  • thermophilic fungal expression systems may be particularly suitable for the expression of temperature-resistant proteins or variants.
  • the host cells according to the invention are conventionally cultivated and fermented, for example in discontinuous or continuous systems.
  • a suitable nutrient medium is inoculated with the host cells and the product is harvested from the medium after an experimentally determined period of time.
  • Continuous fermentations are characterized by achieving a flow equilibrium, in which over a relatively long period of time cells partly die out but also regrow and at the same time the protein formed can be removed from the medium.
  • Host cells according to the invention are preferably used to produce proteases according to the invention.
  • Another object of the invention is therefore a method for preparing a protease comprising
  • This subject invention preferably comprises fermentation processes. Fermentation processes are known per se from the prior art and represent the actual large-scale production step, usually followed by a suitable purification method of the product produced, for example the protease according to the invention. All fermentation processes which are based on a corresponding process for the preparation of a protease according to the invention represent embodiments of this subject matter of the invention.
  • Fermentation processes which are characterized in that the fermentation is carried out via a feed strategy, come in particular into consideration.
  • Supplied with media components consumed by ongoing cultivation are the Supplied with media components consumed by ongoing cultivation.
  • the fermentation can also be designed so that undesired metabolic products are filtered out or neutralized by the addition of buffer or suitable counterions.
  • the protease produced can be harvested from the fermentation medium. Such a fermentation process is resistant to isolation of the protease from the host cell, i. a product preparation from the cell mass (dry matter) preferred, but requires the
  • suitable host cells or one or more suitable secretion markers or mechanisms and / or transport systems for the host cells to secrete the protease into the fermentation medium.
  • the isolation of the protease from the host cell i. a purification of the same from the cell mass, carried out, for example by precipitation with ammonium sulfate or ethanol, or by chromatographic purification.
  • Another object of the invention is an agent which is characterized in that it contains a protease according to the invention as described above.
  • the agent is preferably a washing or cleaning agent.
  • This subject matter of the invention includes all conceivable types of detergents or cleaners, both concentrates and undiluted agents, for use on a commercial scale, in the washing machine or in hand washing or cleaning. These include detergents for textiles, carpets, or natural fibers for which the
  • Label detergent is used. These include, for example, dishwashing detergents for dishwashers or manual dishwashing detergents or cleaners for hard surfaces such as metal, glass, porcelain, ceramics, tiles, stone, painted surfaces, plastics, wood or leather, for which the term detergent is used, ie in addition to manual and machine Dishwashing agents, for example, scouring agents, glass cleaners, toilet scenters, etc.
  • the washing and cleaning agents in the invention also include washing aids which are added to the actual detergent in the manual or machine textile laundry to achieve a further effect. Furthermore count to washing and
  • Textilvor- and post-treatment agent ie those means with which the garment is brought into contact before the actual laundry, for example, to dissolve stubborn dirt, and also such agents in one the actual textile laundry downstream step give the laundry further desirable properties such as comfortable grip, crease resistance or low static charge.
  • the fabric softeners are calculated.
  • washing or cleaning agents according to the invention which may be in the form of homogeneous solutions or suspensions in the form of powdered solids, may contain, in addition to a protease according to the invention, all known ingredients customary in such agents, preferably at least one further ingredient being present in the composition ,
  • the agents according to the invention may in particular be surfactants, builders,
  • Containing peroxygen compounds or bleach activators may contain water-miscible organic solvents, further enzymes, sequestering agents, electrolytes, pH regulators and / or further auxiliaries such as optical brighteners, grayness inhibitors, foam regulators, as well as dyes and fragrances, and combinations thereof.
  • a combination of a protease according to the invention with one or more further ingredients of the composition is advantageous, since such an agent is preferred
  • Embodiments of the invention has improved cleaning performance by resulting synergisms.
  • a protease according to the invention with a surfactant and / or a builder (builder) and / or a peroxygen compound and / or a bleach activator, such a synergism can be achieved.
  • Patent Application WO2009 / 121725 beginning on page 5, penultimate paragraph, and ending on page 13 after the second paragraph. This disclosure is incorporated herein by reference and the disclosure is incorporated herein by reference.
  • An agent according to the invention advantageously contains the protease in an amount of from 2 ⁇ g to 20 mg, preferably from 5 ⁇ g to 17.5 mg, more preferably from 2 ⁇ g to 15 mg and very particularly preferably from 5 ⁇ g to 10 mg per g of the composition.
  • the protease may be advantageously contained in the agent in an amount of 1 x 10 -8 to 5 weight percent based on active protein. More preferably, the protease is in an amount of from 1 x 10 -7 to 3 wt%, from 0.00001 to 1 wt%, from 0.00005 to 0.5 wt%, from 0.0001 to 0, 1 wt .-% and particularly preferably from 0.0001 to 0.05 wt .-% in inventive compositions.
  • the protease contained in the agent, and / or other ingredients of the agent may be coated with a substance impermeable to the enzyme at room temperature or in the absence of water, which becomes permeable to the enzyme under conditions of use of the agent.
  • a substance impermeable to the enzyme at room temperature or in the absence of water which becomes permeable to the enzyme under conditions of use of the agent.
  • the washing or cleaning agent itself in a Container preferably an air-permeable container, be packaged, from which it is released shortly before use or during the washing process.
  • the agent is characterized in that it
  • (A) is in solid form, in particular as a free-flowing powder having a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l, or
  • (b) is in pasty or liquid form, and / or
  • (c) is present as a one-component system, or
  • compositions according to the invention include all solid, powdered, liquid, gelatinous or paste-like administration forms of compositions according to the invention, which if appropriate can also consist of several phases and can be present in compressed or uncompressed form.
  • the agent can be present as a free-flowing powder, in particular with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l or 600 g / l to 850 g / l.
  • the solid dosage forms of the composition also include extrudates, granules, tablets or pouches.
  • the agent can also be liquid, gelatinous or pasty, for example in the form of a non-aqueous liquid detergent or a non-aqueous paste or in the form of an aqueous liquid detergent or a water-containing paste.
  • agent may be present as a one-component system. Such funds consist of one phase. Alternatively, an agent can also consist of several phases. Such an agent is therefore divided into several components.
  • Detergents or cleaning agents according to the invention may contain only one protease. Alternatively, they may also contain other hydrolytic enzymes or other enzymes in a concentration effective for the effectiveness of the agent. A further embodiment of the invention thus represents agents which further comprise one or more further enzymes.
  • enzymes which can be used as further enzymes are all enzymes which can develop a catalytic activity in the agent according to the invention, in particular a further protease, an amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, xyloglucanase, ⁇ -glucosidase, pectinase, carrageenase, Perhydrolase, oxidase, oxidoreductase or a lipase, and mixtures thereof.
  • each additional enzyme is in an amount of 1 x 10 -3 ⁇ 7 wt .-%, of 0.00001-1 wt .-%, of 0.00005 to 0.5 wt .-%, from 0.0001 to 0, 1 wt .-% and particularly preferably from 0.0001 to 0.05 wt .-% in agents according to the invention, based on active protein.
  • the enzymes show synergistic cleaning performance against certain stains or stains, ie the enzymes contained in the middle composition mutually support each other in their cleaning performance.
  • a further subject of the invention is a process for the purification of textiles or hard surfaces, which is characterized in that an agent according to the invention is used in at least one process step, or in at least one process step, a protease of the invention becomes catalytically active, in particular such that the protease in an amount of 4C ⁇ g to 4g, preferably from 5C ⁇ g to 3g, more preferably from 10C ⁇ g to 2g, and most preferably from 20C ⁇ g to 1g is used.
  • Methods for cleaning textiles are generally distinguished by the fact that various cleaning-active substances are applied to the items to be cleaned and washed off after the contact time, or that the items to be cleaned are otherwise treated with a detergent or a solution or dilution of this product.
  • All conceivable washing or cleaning processes can be enriched in at least one of the process steps by the use of a washing or cleaning agent or a protease according to the invention and then represent embodiments of the present invention.
  • All facts, objects and embodiments, which proteases according to the invention and containing them Means are described are also applicable to this subject invention. Therefore, reference is made at this point expressly to the disclosure in the appropriate place with the statement that this disclosure also applies to the above inventive method.
  • proteases according to the invention naturally already have a hydrolytic activity and also unfold them in media which otherwise have no cleaning power, for example in bare buffer, a single and / or the sole step of such a method may be that, if desired, the only cleaning-active component is an inventive Protease is brought into contact with the soiling, preferably in a buffer solution or in water. This represents a further embodiment of this subject of the invention.
  • Alternative embodiments of this subject matter of the invention are also processes for the treatment of textile raw materials or for textile care, in which at least one Process step, a protease of the invention is active.
  • a protease of the invention is active.
  • methods for textile raw materials, fibers or textiles with natural components are preferred, and especially for those with wool or silk.
  • Another subject of the invention is the use of an agent according to the invention for cleaning textiles or hard surfaces, or a protease according to the invention for the purification of textiles or hard surfaces, in particular such that the protease in an amount of 4C ⁇ g to 4g, preferably 5C ⁇ g to 3g, more preferably from 10C ⁇ g to 2g, and most preferably from 20C ⁇ g to 1g is used.
  • Pleurotus pulmonarius Numerous supernatants from basidiomycete cultures were tested for their proteolytic activity. These samples were tested for their cleaning power on various proteinaceous soils in a small scale rapid test.
  • the culture concentrate of Pleurotus pulmonarius showed a measurable washing performance.
  • the culture supernatant of Pleurotus pulmonarius was therefore purified by ion exchange chromatography with a HiTrap SP Sepharose XL column (GE Healthcare, 1 ml) and 20 mM sodium acetate buffer pH 6 with 1 M sodium chloride. For this, 5 mL of the supernatant were mixed 1: 1 with the buffer and purified by chromatography at a flow rate of 1 mL / min with a stepwise gradient of increasing ionic strength. Fractionation yielded a 32 kDa proteolytic protein.
  • the protein was fractionated by gel electrophoresis, the band excised and analyzed by ESI tandem mass spectrometry. Three peptides were identified which showed homology to serine peptidases. All three peptides showed homology to the peptidase POP1 from Pleurotus ostreatus (ACR25273.1 JGI genome data base, protein ID 1088545).
  • Total P. pulmonarius DNA was isolated using the NucleoSpin® RNA Plant Kit (Macherey & Nagel, DE) from approximately 250 mg fresh mycelia taken after four days of culture. ssDNA synthesis was performed with a SMARTScribe reverse
  • UTRJw 5'-AGCCTCTAACCAGCCCACTT-3 '(SEQ ID NO: 2)
  • UTR_rev 5'-CTATCTAGGCGATGCCGAAG-3 '(SEQ ID NO: 3)
  • the gene sequence could be identified and translated into a protein sequence.
  • the protein was identified as a protease with homology to the P. ostreatus peptidase POP1.
  • SEQ ID NO: 4 indicates the deduced protein sequence including signal and propeptide.
  • SEQ ID NO: 6 is the protein sequence including propeptide.
  • nucleic acid sequence encoding the protease including the propeptide i. SEQ ID NO: 6 encoded in a Bacillus expression vector for the
  • Protease production cloned which includes a Bacillus protease signal sequence.
  • Standardized soiled textiles were used for this example. There were the following
  • C Blood milk on cotton: CFT C-05 available from CFT (Center For Testmaterials) B.V.
  • E egg yolk on cotton: WFK 10EG
  • control detergent used was a detergent base formulation of the following composition (all figures in percentages by weight): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7%
  • Glycerine 0.3-0.5% ethanol, 4-7% FAEOS (fatty alcohol ether sulfate), 24-28% nonionic surfactants, 1% boric acid, 1 -2% sodium citrate (dihydrate), 2-4% soda, 14-16 % Coconut fatty acids, 0.5% HEDP (1-hydroxyethane- (1, 1-di-phosphonic acid)), 0-0.4% PVP (polyvinylpyrrolidone), 0-0.05% optical brightener, 0-0.001% Dye, remainder demineralized water.
  • the detergent base formulation was treated with the proteases for the different series of active protein (0.03% by weight active substance).
  • the protease according to the invention used was the protease disclosed in SEQ ID NO.1.
  • protease according to the invention shows comparable cleaning performance on the soiled soils tested as the established enzymes ROC and subtilisin Carlsberg.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)

Abstract

L'invention concerne des protéases comprenant une séquence d'acides aminés représentée par SEQ ID N° 1 et des variants de celles-ci, ainsi que leur préparation et leur utilisation. Les protéases de ce type présentent une bonne performance de nettoyage lorsqu'elles sont utilisées dans des produits de lavage.
PCT/EP2014/076976 2013-12-19 2014-12-09 Protéases fongiques et leur utilisation dans des produits de lavage et de nettoyage WO2015091089A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14827182.8A EP3083955A1 (fr) 2013-12-19 2014-12-09 Protéases fongiques et leur utilisation dans des produits de lavage et de nettoyage

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013226729.0A DE102013226729A1 (de) 2013-12-19 2013-12-19 Pilzliche Proteasen und deren Verwendung in Wasch- und Reinigungsmitteln
DE102013226729.0 2013-12-19

Publications (1)

Publication Number Publication Date
WO2015091089A1 true WO2015091089A1 (fr) 2015-06-25

Family

ID=52347274

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/076976 WO2015091089A1 (fr) 2013-12-19 2014-12-09 Protéases fongiques et leur utilisation dans des produits de lavage et de nettoyage

Country Status (3)

Country Link
EP (1) EP3083955A1 (fr)
DE (1) DE102013226729A1 (fr)
WO (1) WO2015091089A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008131938A1 (fr) * 2007-04-25 2008-11-06 Nestec S.A. Peptidases issues de basidiomycètes
WO2011141358A2 (fr) * 2010-05-12 2011-11-17 Henkel Ag & Co. Kgaa Détergent ou nettoyant liquide stable au stockage contenant une protéase et une lipase
WO2012048334A2 (fr) * 2010-10-08 2012-04-12 Dyadic International (Usa) Inc. Nouvelles protéases fongiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008017103A1 (de) 2008-04-02 2009-10-08 Henkel Ag & Co. Kgaa Wasch- und Reinigungsmittel enthaltend Proteasen aus Xanthomonas

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008131938A1 (fr) * 2007-04-25 2008-11-06 Nestec S.A. Peptidases issues de basidiomycètes
WO2011141358A2 (fr) * 2010-05-12 2011-11-17 Henkel Ag & Co. Kgaa Détergent ou nettoyant liquide stable au stockage contenant une protéase et une lipase
WO2012048334A2 (fr) * 2010-10-08 2012-04-12 Dyadic International (Usa) Inc. Nouvelles protéases fongiques

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JANA ERJAVEC ET AL: "Proteins of higher fungi from forest to application", TRENDS IN BIOTECHNOLOGY, vol. 30, no. 5, 1 May 2012 (2012-05-01), pages 259 - 273, XP028415840, ISSN: 0167-7799, [retrieved on 20120120], DOI: 10.1016/J.TIBTECH.2012.01.004 *
JAOUADI B ET AL: "Biochemical and molecular characterization of a detergent-stable serine alkaline protease from Bacillus pumilus CBS with high catalytic efficiency", BIOCHIMIE, MASSON, PARIS, FR, vol. 90, no. 9, 1 September 2008 (2008-09-01), pages 1291 - 1305, XP023183041, ISSN: 0300-9084, [retrieved on 20080320], DOI: 10.1016/J.BIOCHI.2008.03.004 *
MONIKA PRAKASH ET AL: "Purification and Characterization of <I>Bacillus cereus</I> Protease Suitable for Detergent Industry", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 127, no. 3, 1 January 2005 (2005-01-01), pages 143 - 156, XP055174969, DOI: 10.1385/ABAB:127:3:143 *
See also references of EP3083955A1 *

Also Published As

Publication number Publication date
DE102013226729A1 (de) 2015-06-25
EP3083955A1 (fr) 2016-10-26

Similar Documents

Publication Publication Date Title
EP2771459B1 (fr) Variants des proteases avec des performances ameliorees et insensibles a temperature
EP4114934A1 (fr) Variants de protéase vi à stabilité améliorée
EP2545169B1 (fr) Proteases avec des efficiences ameliorées
WO2019048495A1 (fr) Variantes de protéases à performances améliorées
WO2019048486A1 (fr) Variantes de protéases à performances améliorées
EP3058057A1 (fr) Variants de protéase à stabilité accrue
EP3433360B1 (fr) Protéases présentant une meilleure stabilité enzymatique dans les détergents
WO2015044206A1 (fr) Variantes de protéases inhibitrices stabilisées
WO2019048488A1 (fr) Variantes de protéase à performances améliorées
EP2683808B1 (fr) Variantes de protéase à performance améliorée
EP3433359B1 (fr) Performance de nettoyage améliorée sur des salissures sensibles aux protéines
EP3458583A1 (fr) Protéases à performance améliorée
EP3440203B1 (fr) Nouvelle protéase à performance de lavage améliorée
DE102012220101A1 (de) Leistungsverbesserte Proteasevarianten
WO2015091089A1 (fr) Protéases fongiques et leur utilisation dans des produits de lavage et de nettoyage
EP2585590A1 (fr) Nouvelles protéases et agents les contenant
DE102018208777A1 (de) Leistungsverbesserte Proteasevarianten V
DE102017215631A1 (de) Leistungsverbesserte Proteasevarianten II
WO2010146036A1 (fr) Nouvelles protéases et agents renfermant ces protéases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14827182

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2014827182

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014827182

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE